Relevant bibliographies by topics / Pharmacotherapy safety

Contents

  1. Journal articles
  2. Books
  3. Book chapters
  4. Conference papers

Academic literature on the topic 'Pharmacotherapy safety'

Author: Grafiati
Published: 4 June 2025
Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pharmacotherapy safety.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pharmacotherapy safety"

1

O'Malley, Kieran D. "Safety of Combined Pharmacotherapy." Journal of the American Academy of Child & Adolescent Psychiatry 36, no. 11 (1997): 1489–90. http://dx.doi.org/10.1097/00004583-199711000-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

O'Malley, Kieran D. "SAFETY OF COMBINED PHARMACOTHERAPY." Journal of the American Academy of Child & Adolescent Psychiatry 36, no. 11 (1997): 1489–90. http://dx.doi.org/10.1016/s0890-8567(09)66552-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Roehrs, Timothy, and Thomas Roth. "Safety of Insomnia Pharmacotherapy." Sleep Medicine Clinics 1, no. 3 (2006): 399–407. http://dx.doi.org/10.1016/j.jsmc.2006.06.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pasechnik, I. N., V. Yu Rybintsev, and P. A. Talyzin. "Safety of pharmacotherapy: what's new?" Anesteziologiya i Reanimatologiya, no. 5 (2019): 47. http://dx.doi.org/10.17116/anaesthesiology201905147.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sychev, D. A. "Pharmacotherapy Safety 360°: NOLI NOCERE!" Pharmacogenetics and Pharmacogenomics, no. 1 (July 19, 2023): 3–5. http://dx.doi.org/10.37489/2588-0527-2023-1-3-5.

Full text
Abstract:
The Russian Congress «Pharmacotherapy Safety 360°: NOLI NOCERE!» was successfully held at the Russian Ministry of Health in May 2023, providing a high-level, expert platform to discuss current and topical issues of pharmacovigilance and pharmacotherapy safety for different patient groups, including pediatrics, gerontology and geriatrics, pregnant women, patients with orphan and oncological diseases. Extensive scientific topics covered the most significant aspects of the pharmacotherapy safety in various fields, including cardiology, gastroenterology, pulmonology and allergology, endocrinology,
APA, Harvard, Vancouver, ISO, and other styles
6

Tezel, Tongalp H. "Intraocular pharmacotherapy: specificity and safety issues." Expert Review of Ophthalmology 2, no. 5 (2007): 671–75. http://dx.doi.org/10.1586/17469899.2.5.671.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lukina, Yu V., N. P. Kutishenko, S. Yu Martsevich, and O. M. Drapkina. "Issues of concern and development of classifications of the main parameters of therapy quality and compliance. Part III: quality of pharmacotherapy." Cardiovascular Therapy and Prevention 23, no. 12 (2024): 4268. https://doi.org/10.15829/17288800-2024-4268.

Full text
Abstract:
This article is the third work in a series of publications on consideration of the main parameters of therapy quality and compliance and the development of their classifications. The aim is to determine, based on scientific literature data, the main parameters reflecting the quality of therapy and to develop their classification.According to the World Health Organization, more than half of all drugs are prescribed and sold improperly, and half of all patients take their medications inadequately. To date, there is no generally accepted terminology and classification regarding the quality of the
APA, Harvard, Vancouver, ISO, and other styles
8

Wigal, Sharon B. "Safety and Efficacy Limitations of ADHD Pharmacotherapy." Journal of Pediatrics 154, no. 5 (2009): I—S43. http://dx.doi.org/10.1016/j.jpeds.2009.01.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Masand, Prakash S., Farhan S. Fazal, and Ashwin A. Patkar. "Safety Considerations in Pharmacotherapy of Bipolar Disorder." CNS Spectrums 9, S12 (2004): 16–26. http://dx.doi.org/10.1017/s1092852900028856.

Full text
Abstract:
AbstractBipolar disorder is a chronic, frequently relapsing illness with a prevalence of 1.2% to 3.4% in the general population. It is associated with high disability, higher comorbidity due to medical illnesses, and significant social and economical consequences for patients, their families, and society. The episodic nature of this disease warrants rational use of medications and proper monitoring for adverse events. Various drug classes, such as mood stabilizers, antipsychotics, benzodiazepines, and antidepressants, are used for the acute and maintenance treatment of bipolar disorder. Each g
APA, Harvard, Vancouver, ISO, and other styles
10

Johannessen Landmark, Cecilie, and Svein I Johannessen. "Pharmacotherapy in epilepsy – does gender affect safety?" Expert Opinion on Drug Safety 15, no. 1 (2015): 1–4. http://dx.doi.org/10.1517/14740338.2016.1117606.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Pharmacotherapy safety"

1

Lam, Raymond W. Pharmacotherapy. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199692736.003.0007.

Full text
Abstract:
• The newer antidepressants (SSRIs, SNRIs, other receptor agents) are first-line medications due to improved safety and tolerability over first-generation medications (TCAs, MAOIs).• Selection of an antidepressant must take into account efficacy, depression subtype, safety, side effect profile, simplicity of use, comorbid conditions, concurrent medications, and cost....
APA, Harvard, Vancouver, ISO, and other styles
2

Asherson, Philip, and Josep Antoni Ramos-Quiroga. Treatment in adult ADHD. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198739258.003.0046.

Full text
Abstract:
The treatment of ADHD in adults is very similar to that recommended for children and adolescents. There have been many more clinical trials evaluating the efficacy and safety of the drugs used in ADHD treatment on children than adults. Pharmacotherapy for adults with ADHD has been shown to be effective. The National Institute of Health and Care Excellence (NICE) guidelines recommend pharmacotherapy as first-line treatment for adult ADHD. The NICE guidelines consider stimulants (methylphenidate and dexamfetamine) as the first choice for treatment of adult ADHD, and the non-stimulant atomoxetine
APA, Harvard, Vancouver, ISO, and other styles
3

Wijdicks, Eelco F. M., and Sarah L. Clark. Drugs Used to Treat Withdrawal Syndromes. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190684747.003.0018.

Full text
Abstract:
This chapter covers the treatment of withdrawal syndromes associated with alcohol, opioids, stimulants, baclofen, and nicotine. The approach to refractory withdrawal delirium is discussed, as well as the management of serious withdrawal syndromes that are neurology-specific, such as baclofen withdrawal. Withdrawal syndromes are serious and may require extensive pharmacotherapy. The safety of the patient must be balanced against the risks and side effects of the medications administered to control the agitation. Prior alcoholism accounts for the overwhelming proportion of patients with withdraw
APA, Harvard, Vancouver, ISO, and other styles
4

Krystal, John H., and Dennis S. Charney. Current Treatments for Depression. Edited by Dennis S. Charney, Eric J. Nestler, Pamela Sklar, and Joseph D. Buxbaum. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190681425.003.0031.

Full text
Abstract:
Depression is among the most common and disabling medical disorders worldwide. Pharmacotherapy plays an important role in its treatment, although only half of all depressed patients show full remission with currently available therapies. This chapter reviews the most common pharmacotherapies with respect to their mechanisms of action, efficacy, tolerability, and safety. It also considers pharmacologic approaches to treatment-resistant symptoms of depression including adjunctive pharmacotherapies and the emerging rapid-acting antidepressants. An important focus of current research is to devise
APA, Harvard, Vancouver, ISO, and other styles
5

Wakeman, Sarah E., and Josiah D. Rich. Pharmacotherapy for substance use disorders within correctional facilities. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199360574.003.0046.

Full text
Abstract:
Drug addiction treatment is increasingly complex. Only 5% of prisons and 34% of jails offer any detoxification services, and only 1% of jails offer methadone for opioid withdrawal. Even fewer facilities offer medication assisted therapy (MAT) for alcohol or substance use disorders despite the tremendous evidence base supporting the use of medications to treat addiction. Untreated opioid dependence both within corrections and in the community is associated with HIV, Hepatitis C, crime, and death by overdose. Substantial evidence argues that these risks are reduced through long-term treatment wi
APA, Harvard, Vancouver, ISO, and other styles
6

Wakeman, Sarah E., and Josiah D. Rich. Pharmacotherapy for substance use disorders within correctional facilities. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199360574.003.0046_update_001.

Full text
Abstract:
Drug addiction treatment is increasingly complex. Only 5% of prisons and 34% of jails offer any detoxification services, and only 1% of jails offer methadone for opioid withdrawal. Even fewer facilities offer medication assisted therapy (MAT) for alcohol or substance use disorders despite the tremendous evidence base supporting the use of medications to treat addiction. Untreated opioid dependence both within corrections and in the community is associated with HIV, Hepatitis C, crime, and death by overdose. Substantial evidence argues that these risks are reduced through long-term treatment wi
APA, Harvard, Vancouver, ISO, and other styles
7

Hao, Joy, Rae Lynne Kinler, Eliezer Soto, Helena Knotkova, and Ricardo A. Cruciani. Neurostimulation in pain management. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656097.003.0099.

Full text
Abstract:
Neurostimulation describes an array of interventions that involve targeted stimulation of peripheral nerve, spinal cord, or the brain. Although few high-quality studies of neurostimulation techniques have been done and the techniques are seldom used in the management of pain related to serious illness, a better understanding of the available treatments and the emergence of newer technologies may increase access and use in the future. Transcutaneous electrical nerve stimulation is considered to be safe and may be used as an adjunct to pharmacotherapy in the routine management of chronic pain. C
APA, Harvard, Vancouver, ISO, and other styles
8

Clark, Caroline, Jeffrey Cole, Christine Winter, and Geoffrey Grammer. Transcranial Magnetic Stimulation Treatment of Posttraumatic Stress Disorder. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190205959.003.0005.

Full text
Abstract:
Symptoms of post-traumatic stress disorder (PTSD) often fail to resolve with psychotherapy, pharmacotherapy, or integrative medicine treatments. Given these limitations, there is a continued push to discover treatment methods utilizing novel mechanisms of action. Transcranial magnetic stimulation (TMS) offers a non-invasive and safe method of brain stimulation that modulates neuronal activity in a focal area to achieve excitation or inhibition, and may have utility for patients suffering from PTSD, although, to date, evidence of efficacy is limited. The TMS treatment can be varied to suit the
APA, Harvard, Vancouver, ISO, and other styles
9

Kočka, Viktor, Steen Dalby Kristensen, William Wijns, Petr Toušek, and Petr Widimský. Percutaneous coronary interventions in acute coronary syndromes. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0047.

Full text
Abstract:
Three different guidelines of the European Society of Cardiology cover the field of percutaneous coronary interventions. Their main recommendations are the following:All patients with an ST-segment elevation myocardial infarction should undergo immediate coronary angiography and percutaneous coronary intervention as soon as possible after the first medical contact. Thrombolysis can be used as an alternative reperfusion therapy if the time delay to primary percutaneous coronary intervention is more than 2 hoursPatients with very high-risk non-ST-segment elevation acute coronary syndromes (recur
APA, Harvard, Vancouver, ISO, and other styles
10

Kočka, Viktor, Steen Dalby Kristensen, William Wijns, Petr Toušek, and Petr Widimský. Percutaneous coronary interventions in acute coronary syndromes. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199687039.003.0047_update_001.

Full text
Abstract:
Three different guidelines of the European Society of Cardiology cover the field of percutaneous coronary interventions. Their main recommendations are the following:All patients with an ST-segment elevation myocardial infarction should undergo immediate coronary angiography and percutaneous coronary intervention as soon as possible after the first medical contact. Thrombolysis can be used as an alternative reperfusion therapy if the time delay to primary percutaneous coronary intervention is more than 2 hoursPatients with very high-risk non-ST-segment elevation acute coronary syndromes (recur
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Pharmacotherapy safety"

1

Stewart, Michael W. "Safety Considerations of Pharmacotherapy." In Diabetic Retinopathy. Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-3509-8_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rissanen, Antti, and Marjo Rissanen. "Health Informatics and Patient Safety in Pharmacotherapy." In Health Information Science. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-99-7108-4_31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Russell, Stuart D. "Exercise in Heart Failure: Effectiveness Versus Safety." In Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-15961-4_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hanh, Jacky, Philip Hazell, and Isabelle Feijo. "The Pharmacist and Pharmacotherapy." In Longer-Term Psychiatric Inpatient Care for Adolescents. Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-19-1950-3_17.

Full text
Abstract:
AbstractClinical pharmacy services aim to optimise health outcomes and improve patient safety throughout all steps of the medicines management pathway, by ensuring the quality use of medicines and minimising medication-related problems. The role of the pharmacist includes gathering and documenting medication histories, performing medication reconciliation and undertaking clinical medication reviews. These services support collaborative approaches between patients, carers and the multidisciplinary team to develop patient-centred medication management plans. The practice of pharmacotherapy at th
APA, Harvard, Vancouver, ISO, and other styles
5

Herxheimer, Andrew. "Strategies for Improving Drug Safety in Europe: Can General Practitioners Contribute ?" In Rationale Pharmakotherapie in der Allgemeinpraxis / Rational Pharmacotherapy in General Practice. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-76731-9_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Liakoni, Evangelia, and Neal L. Benowitz. "Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy." In Supporting Tobacco Cessation. European Respiratory Society, 2021. http://dx.doi.org/10.1183/2312508x.10002420.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hirsch, Calvin H., Shyam Maharaj, and James A. Bourgeois. "Pharmacotherapy: Safe Prescribing and Adverse Drug Events." In Geriatric Psychiatry. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-47802-4_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hirsch, Calvin H., Shyam Maharaj, and James A. Bourgeois. "Pharmacotherapy: Safe Prescribing and Adverse Drug Events." In Geriatric Psychiatry. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-67555-8_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Simsek, Dilbirin, and Mahmut Bulut. "The Role of Ect in Depression." In Depression Treatment Updates. Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359456.3.

Full text
Abstract:
Electroconvulsive therapy (ECT) originated in Italy in the 1930s and regained significance in the 1980s due to its efficacy in cases where psychotropic drugs were insufficient. Today, it’s a safe and effective treatment for major depression, mania, schizophrenia, and catatonia. Public misconceptions about ECT exist, leading to reluctance among patients and physicians. Advancements in technology have minimized cognitive side effects, making ECT less risky than pharmacotherapy, especially during pregnancy. Indications for ECT include suicidal thoughts, treatment-resistant depression, contraindic
APA, Harvard, Vancouver, ISO, and other styles
10

A, Shannumukha Sainath. "Medication Safety." In Evidence-Based Pharmacotherapy in Clinical Practice. THINKPLUS PHARMA PUBLICATIONS, 2025. https://doi.org/10.69613/afnpcb56.

Full text
Abstract:
Medication safety protocols include systematic error prevention strategies and risk management systems across healthcare settings. Error prevention mechanisms utilize standardized procedures, technological interventions, and human factors engineering principles to minimize medication-related adverse events. High-alert medication management requires specific safety protocols including standardized concentrations, independent double-checks, and restricted access systems. Risk management programs implement proactive assessment tools, incident reporting systems, and root cause analysis protocols f
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pharmacotherapy safety"

1

Gradwohl, C., H. Pichler, G. Engstler, F. Nagele, M. Anditsch, and G. Stemer. "4CPS-207 Improving the safety of pharmacotherapy in paediatric haemato-oncology by clinical pharmacy services." In 26th EAHP Congress, Hospital pharmacists – changing roles in a changing world, 23–25 March 2022. British Medical Journal Publishing Group, 2022. http://dx.doi.org/10.1136/ejhpharm-2022-eahp.207.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Вакурова, Н. В., Т. А. Азовскова, and С. А. Бабанов. "Compliance as the most important condition for the effectiveness of pharmacotherapy in patients with occupational chronic obstructive pulmonary disease." In III International Scientific Forum "Health And Safety At The Workplace". Polikraft, 2019. http://dx.doi.org/10.31089/978-985-7153-76-3-2019-1-3-57-60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Liang Hwu, Paul Wuh, Yin Hsiu Chien, Ni Chung Lee, et al. "Safety and Improved Efficacy Outcomes in Children With AADC Deficiency Treated With Eladocagene Exuparvovec Gene Therapy: Results From Three Clinical Trials." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.049.

Full text
Abstract:
Introduction: aromatic L-amino acid decarboxylase (AADC) deficiency, a rare genetic disorder of neurotransmitter synthesis, is characterized by motor developmental deficits and clinical features associated with the autonomic nervous system, including dyskinesia, and oculogyric crisis. Objective: To evaluate clinical outcomes in children with AADC deficiency treated with eladocagene exuparvovec, a recombinant adeno-associated virus vector containing the human cDNA encoding the AADC enzyme. Methods: In 3 open-label clinical studies, children with AADC deficiency who had no full head control and
APA, Harvard, Vancouver, ISO, and other styles
4

Madić, Višnja, Aleksandra Petrović, and Perica Vasiljević. "ETHNOPHARMACOLOGY OF DIABETES: FROM TRADITIONAL RECIPES TO MODERN MEDICINE." In 58. Kongres Antropološkog društva Srbije. Antropološko društvo Srbije, 2025. https://doi.org/10.46793/ads25.34m.

Full text
Abstract:
Diabetes is one of the most prevalent chronic diseases of the 21st century. Current pharmacological interventions used in the management of this condition regulate hyperglycemia; however, they do not fully prevent the onset or progression of its secondary complications, including diabetic nephropathy, hepatic dysfunction, osteoporosis, neuropathy, retinopathy, cardiovascular diseases, increased risk of dementia, etc. Consequently, a growing number of individuals with diabetes, in addition to conventional pharmacotherapy, are incorporating herbal alternatives derived from traditional medicine,
APA, Harvard, Vancouver, ISO, and other styles
5

Khalikov, S. S. "FEATURES OF MECHANOCHEMICAL TECHNOLOGY IN THE DEVELOPMENT OF PARASITOCIDES." In THEORY AND PRACTICE OF PARASITIC DISEASE CONTROL. All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV”, 2023. http://dx.doi.org/10.31016/978-5-6048555-6-0.2023.24.498-502.

Full text
Abstract:
The purpose of the research is to study the features of the mechanochemical
 modification of medicinal substances with low solubility in water. According to
 the Biopharmaceutics Classification System, about 6% of medicinal substances
 belong to the group of insoluble medicinal substances, and about 47%, to practically
 insoluble medicinal substances, i.e. more than a half substances have problems with
 solubility, and therefore bioavailability and pharmacological activity. To achieve
 the therapeutic effect of such substances, it is necessary to deliberately incr
APA, Harvard, Vancouver, ISO, and other styles
6

Magowska, Anita. "Nineteenth-century cholera epidemics as a factor in the modernization of pharmacy." In 46th INTERNATIONAL CONGRESS FOR THE HISTORY OF PHARMACY. Pharmaceutical Association of Serbia, 2024. http://dx.doi.org/10.46793/ishp46.109m.

Full text
Abstract:
The paper focuses on the beginnings of pharmacy modernisation, i.e., introducing statistical methods into pharmacotherapy assessment to meet the individual and population’s health needs. The work is based on 19th-century archival records, medical press, doctoral theses on cholera, pharmacotherapy textbooks and pharmacopoeias. The study covers 1817-1883, i.e. from the first cholera pandemic to the discovery of the bacterial aetiology of this disease by Robert Koch. In the 19th century, a high toll of death from cholera forced doctors to search for effective and safe anti-choleric drugs. They le
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pharmacotherapy safety' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography